LTP News Sharing:

Recent research on longevity is making the idea of an elixir of life sound increasingly plausible. But a startup that’s started selling a $1 million anti-aging treatment is most likely jumping the gun. Libella Gene Therapeutics says it will administer volunteers with a gene therapy that it claims can reverse aging by up to 20 years, according to OneZero. Despite the fact that this is the first human trial of the treatment, the company is charging volunteers $1m to take part. In an effort to side-step the FDA, the trial will take place in Colombia. The therapy will attempt to…

Go to Source